Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 6, Issue 2, Pages e393-e393
Publisher
Springer Nature
Online
2016-02-05
DOI
10.1038/bcj.2016.5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome
- (2015) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
- (2015) Moritz Gerstung et al. Nature Communications
- Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
- (2015) Anand Balasubramani et al. Nature Communications
- Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
- (2015) M M Patnaik et al. Blood Cancer Journal
- Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update
- (2015) Kristen B. McCullough et al. Current Hematologic Malignancy Reports
- Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution
- (2014) Guilin Tang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
- (2014) Emnet A. Wassie et al. AMERICAN JOURNAL OF HEMATOLOGY
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
- (2014) Mrinal M. Patnaik et al. BRITISH JOURNAL OF HAEMATOLOGY
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
- (2014) M M Patnaik et al. LEUKEMIA
- ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
- (2014) Gandhi Damaj et al. PLoS One
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
- (2013) E. Padron et al. BLOOD
- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- SH2B3 (LNK)mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
- (2013) Maya Koren-Michowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- An evolutionary perspective on chronic myelomonocytic leukemia
- (2013) R Itzykson et al. LEUKEMIA
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
- (2013) R R Laborde et al. LEUKEMIA
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Somatic SETBP1 mutations in myeloid malignancies
- (2013) Hideki Makishima et al. NATURE GENETICS
- Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
- (2013) Ayana Kon et al. NATURE GENETICS
- FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2012) Naval Daver et al. AMERICAN JOURNAL OF HEMATOLOGY
- Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
- (2012) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
- (2012) M. M. Patnaik et al. BLOOD
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
- (2012) S.-J. Wu et al. BLOOD
- SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival
- (2012) T. L. Lasho et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
- (2012) Jumpei Yamazaki et al. Epigenetics
- Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases
- (2012) S. Schnittger et al. HAEMATOLOGICA
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
- (2012) Véronique Gelsi-Boyer et al. Journal of Hematology & Oncology
- ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
- (2012) S Schnittger et al. LEUKEMIA
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
- (2011) Y. Shen et al. BLOOD
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
- (2011) M M Patnaik et al. LEUKEMIA
- DNMT3A mutations in myeloproliferative neoplasms
- (2011) F Stegelmann et al. LEUKEMIA
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation
- (2011) Gabriella Ficz et al. NATURE
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
- (2011) M. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
- (2010) C. Ricci et al. CLINICAL CANCER RESEARCH
- Cytogenetic risk stratification in chronic myelomonocytic leukemia
- (2010) E. Such et al. HAEMATOLOGICA
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
- (2010) Alexander Kohlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration
- (2010) O Abdel-Wahab et al. LEUKEMIA
- Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype
- (2010) M M Patnaik et al. LEUKEMIA
- WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations
- (2010) M M Patnaik et al. LEUKEMIA
- Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- (2010) J Boultwood et al. LEUKEMIA
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- PHF6 mutations in T-cell acute lymphoblastic leukemia
- (2010) Pieter Van Vlierberghe et al. NATURE GENETICS
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
- (2009) N Carbuccia et al. LEUKEMIA
- Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
- (2009) A Tefferi et al. LEUKEMIA
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
- (2009) M-C Kuo et al. LEUKEMIA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cohesins Functionally Associate with CTCF on Mammalian Chromosome Arms
- (2008) Vania Parelho et al. CELL
- Cohesin mediates transcriptional insulation by CCCTC-binding factor
- (2008) Kerstin S. Wendt et al. NATURE
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started